Structure Info
- Chemspace ID
- CSCS06744480857 (Synthesis)
- IUPAC Name
- 4-[(10R,11R,15R,16S)-16-{[(2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methyl-hexahydro-2H-pyrano[3,2-d][1,3]dioxin-6-yl]oxy}-12-oxo-4,6,13-trioxatetracyclo[7.7.0.0³,⁷.0¹¹,¹⁵]hexadeca-1,3(7),8-trien-10-yl]-2,6-dimethoxyphenyl (2,2-dimethyl-1,3-dioxolan-4-yl)methyl carbonate
- Mol formula
- C36H42O17
- Mol weight
- 747 Da
- Catalog Number(s)
- HY-123690, T26943
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 2.07
- Heavy atoms count
- 53
- Rotatable bond count
- 10
- Number of rings
- 8
- Carbon bond saturation, Fsp3
- 0.611
- Polar surface area (Å)
- 195
- Hydrogen bond acceptors count
- 15
- Hydrogen bond donors count
- 2
- Zoom the structure
- CSCS06744480857
Items Overall 5 items from 3 suppliers
| Supplier | Lead time | Ships from | Purity | Pack | Price, € | Qty |
|---|---|---|---|---|---|---|
| Targetmol Chemicals Inc | 30 days | United States To: | 90 | 25 mg | 1,520 | |
| Targetmol Chemicals Inc | 30 days | United States To: | 90 | 50 mg | 1,980 | |
| Targetmol Chemicals Inc | 30 days | United States To: | 90 | 100 mg | 2,500 | |
Description: CAP-7.1, a DNA topoisomerase inhibitor, is used potentially for the treatment of biliary cancer and non-small cell lung cancer.; CAS: 433304-61-1 | ||||||
| MedChemExpress | TBD | United States To: | 90 | 1 mg | POA | |
Description: Names: Etoposide toniribate; CAP-7.1; Product Description: Etoposide toniribate is an active compound.; Target: Drug Derivative; CAS: 433304-61-1 | ||||||
| MedChemExpress EU | TBD | Sweden To: | 90 | 1 mg | POA | |
Description: Names: Etoposide toniribate; CAP-7.1; Product Description: Etoposide toniribate is an active compound.; Target: Drug Derivative; CAS: 433304-61-1 | ||||||
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire